Bortezomib in multiple myeloma

Matt Stenger, Vincent Rajkumar

Research output: Contribution to journalShort survey

Abstract

This novel proteasome inhibitor appears to improve response rates and survival in patients with progressive multiple myeloma.

Original languageEnglish (US)
Pages (from-to)77+82
JournalCommunity Oncology
Volume1
Issue number2
DOIs
StatePublished - 2004

ASJC Scopus subject areas

  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Bortezomib in multiple myeloma'. Together they form a unique fingerprint.

  • Cite this